JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265865

Human P2RX5 (P2X5) knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

P2RX5 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 17 bp deletion in exon 2 and 1 bp deletion in exon 2.

View Alternative Names

ATP receptor, ATP receptor subunit, Ionotropic ATP receptor P2X5, LRH-1, Lymphoid restricted histocompatibility antigen 1, MGC47755, P2RX5_HUMAN, P2X purinoceptor 5, P2X5R, Purinergic receptor, Purinergic receptor P2X ligand gated ion channel 5, Purinergic receptor P2X5

2 Images
Sanger Sequencing - Human P2RX5 (P2X5) knockout HeLa cell line (AB265865)
  • Sanger seq

Unknown

Sanger Sequencing - Human P2RX5 (P2X5) knockout HeLa cell line (AB265865)

Allele-1 : 17 bp deletion in exon 2.

Sanger Sequencing - Human P2RX5 (P2X5) knockout HeLa cell line (AB265865)
  • Sanger seq

Unknown

Sanger Sequencing - Human P2RX5 (P2X5) knockout HeLa cell line (AB265865)

Allele-2 : 1 bp deletion in exon 2.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 17 bp deletion in exon 2 and 1 bp deletion in exon 2

Disease

Adenocarcinoma

Product details

Recommended control: Human wild-type HeLa cell line (ab255928). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265865-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265865 Human P2RX5 (P2X5) knockout HeLa cell line", "number":"AB265865-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265865-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265865 Human P2RX5 (P2X5) knockout HeLa cell line", "number":"AB265865-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
P2RX5
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The P2X5 receptor also known as P2RX5 is a member of the P2X family of receptors which are ligand-gated ion channels activated by extracellular ATP. P2X5 is a protein that weighs approximately 53 kDa. It is expressed in various tissues particularly prominent in the immune and nervous system. The receptor facilitates the movement of ions such as calcium sodium and potassium across the cell membrane influencing cellular depolarization and signaling.
Biological function summary

P2X5 plays a significant role in modulating immune responses and synaptic transmission. It forms homomeric or heteromeric complexes with other P2X receptor subtypes like P2X1 and P2X2 affecting its functionality. The receptor's presence in the lymphatic tissues suggests its involvement in lymphocyte proliferation and function. Additionally P2X5 influences neurotransmitter release in neural contexts impacting neuron-to-neuron communication.

Pathways

P2X5 participates prominently in the purinergic signaling pathway and has roles in the immune response pathway. It is involved with related proteins like P2X1 and P2X4 in mediating several physiological functions. In purinergic signaling the activation of P2X5 receptor channels by ATP affects numerous downstream processes involving calcium influx which is critical to the function of both neuronal and immune pathways.

P2X5 has been linked to certain inflammatory conditions and neurological disorders. For instance its pro-inflammatory roles make it a point of interest in studying autoimmune diseases. Furthermore abnormalities in P2X5 activity have been associated with multiple sclerosis implicating it in the demyelination processes. The receptor interacts with pro-inflammatory cytokines and such interactions may exacerbate disease states highlighting the therapeutic potential of targeting P2X5 in treatment interventions.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com